Alexandria Real Estate Equities: Q3 Earnings Snapshot
Alexandria Real Estate Equities (ARE) reported Q3 funds from operations of $1.54 per share, beating estimates. Revenue was $671.2M, also exceeding forecasts. The company expects full-year FFO between $6.38 and $6.42 per share. ARE shares are down 12% YTD and 44% over the past year.
How this was made

The 30-second read
Why it matters
Earnings beat on key metrics but guidance may be viewed as modest, likely pressuring the stock.
Market read
First‑time earnings disclosure for a mid‑cap REIT; relevant for REIT sector traders.
What to watch
Potential upside from upcoming biotech tenant leases and long‑term lease structures not reflected in short‑term guidance.
Background
Alexandria Real Estate Equities (ARE) is a REIT focused on life‑science properties. The article reports its Q3 earnings and FY guidance.
Ticker impact
Q3 earnings released with FFO $1.54/share beating estimates and revenue $671.2M beating forecasts, plus FY guidance guidance $6.38‑$6.42 per share.
likely pressure as investors price in modest FY guidance and recent 12% YTD decline
First report of earnings numbers and guidance for a mid‑cap REIT; guidance below consensus expectations could trigger sell‑off.
Market effects
May weigh on other REITs and life‑science real‑estate peers if guidance is seen as soft.
Limited to U.S. REIT sector.
Low
Counterpoint
If investors focus on the FFO beat and strong cash flow, the stock could rally despite guidance.
Key entities
- companyAlexandria Real Estate Equities Inc.
Life‑science REIT reporting Q3 results.


